• Bacitracin (B1670): Protocol and QC Guide

  2026-08-21

  Bacitracin (B1670) is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis. This guide covers solvent selection, storage, assay controls, and QC while emphasizing that the material is for scientific research only and not for diagnostic or medical use.

• Perphenazine: A Systems View of D2 and Cell Stress

  2026-08-21

  Perphenazine is a dopamine D2 receptor antagonist whose receptor pharmacology intersects with mitochondrial stress and host-cell defense. This article presents a systems-level framework for interpreting perphenazine experiments across neuropharmacology, schizophrenia research, and intracellular infection assays.

• Rosiglitazone A4304: Reliable Cell Assay Workflows

  2026-08-20

  Rosiglitazone (SKU A4304) supports controlled PPARγ activation in adipogenesis, metabolic disease models, and cell-based viability or proliferation assays. This scenario-driven guide explains formulation, stock preparation, interpretation, and vendor-selection decisions that improve experimental comparability without overstating biological conclusions.

• Essential Fe–S Cluster in DNA Polymerase ε

  2026-08-20

  The reference study provides structural and biochemical evidence that DNA polymerase ε contains an essential iron–sulfur cluster bound to the CysX motif in its catalytic core. By combining anomalous-signal crystallography, subunit-complex analysis, enzyme assays, and yeast genetics, the authors connect cluster binding directly to polymerase activity and cell viability.

• Polyphenol-Armored Hydrogel for Aged OA

  2026-08-19

  The reference study develops an injectable, cartilage-adhesive hydrogel that locally delivers miR-140 through polyphenol-armored nanoparticles to address senescent chondrocytes in aged osteoarthritis. Its integrated design combines sustained joint retention, protection of RNA in a reactive microenvironment, improved intracellular delivery, lubrication, and reactive oxygen species control.

• Mycophenolic Acid in Whole-Blood Assays

  2026-08-19

  Mycophenolic acid enables pathway-directed modulation of fresh whole-blood immune assays without removing the cellular and plasma context that shapes cytokine responses. This guide translates a standardized immunometabolism workflow into practical stock preparation, experimental design, troubleshooting, and comparative use cases.

• SMPD4, Ceramide, and Primary Cilia Development

  2026-08-18

  A 2024 Development study links SMPD4-dependent ceramide production to neural progenitor survival, Purkinje cell development, and primary cilium maintenance. By combining a mouse model with SMPD4-deficient human iPSC-derived neural cells and ceramide rescue, the work provides a mechanistic framework for SMPD4-associated microcephaly and cerebellar hypoplasia.

• Viral RIPK3 Degradation Controls Inflammation

  2026-08-18

  Liu et al. identified a viral inducer of RIPK3 degradation, or vIRD, that hijacks host SCF ubiquitin-ligase machinery to remove the necroptosis kinase and reshape orthopoxvirus pathogenesis. Their combination of screening, biochemical validation, engineered viruses, and mouse genetics links proteasomal RIPK3 loss to viral replication, inflammation, and mortality.

• Leupeptin Hemisulfate Salt in Cell Assays

  2026-08-17

  Leupeptin, Microbial (Leupeptin hemisulfate), SKU A2570, helps researchers control protease-driven protein degradation that can confound cell viability, proliferation, cytotoxicity, and autophagy measurements. This scenario-based guide covers mechanism, assay compatibility, solution handling, data interpretation, and practical supplier selection.

• Mycophenolic Acid in Whole-Blood Immunometabolism

  2026-08-16

  Learn how Mycophenolic acid, a dehydrogenase inhibitor, can reveal metabolism-dependent cytokine responses in standardized whole-blood assays. This practical guide covers formulation, dose-finding, controls, comparative applications, and troubleshooting for immunometabolism and infection-focused research.

• Cyanine 5-dCTP for Spatially Controlled DNA Synthesis

  2026-08-15

  Cyanine 5-dCTP enables covalent red-fluorescent labeling during enzymatic DNA synthesis. This article examines how nucleotide chemistry, polymerase accessibility, and ordered DNA interfaces jointly influence assay design and interpretation.

• Chlorin e6: From ROS to Assay Design

  2026-08-15

  Chlorin e6 is more than a light-activated cytotoxic agent: it is an assay-design variable linking illumination, oxygen, localization, and biological readouts. This article explains how the Ce6 photosensitizer supports reproducible cancer and antibacterial photodynamic therapy research while defining the limits of cross-model interpretation.

• (R,S)-Anatabine: From Aβ to Assay Logic

  2026-08-14

  Explore how (R,S)-Anatabine connects amyloid precursor protein processing, BACE-1 regulation, and NF-κB signaling in Alzheimer’s disease models. This article adds a tissue-context perspective from NLRP10 skin biology to improve mechanistic assay design without overextending the evidence.

• AAL-993: Selective VEGF Receptor Inhibitor

  2026-08-14

  AAL-993 is a potent VEGF receptor inhibitor that preferentially targets VEGFR-2 and VEGFR-3 in recombinant kinase assays. Its reported anti-angiogenic activity and melanoma tumor growth inhibition support use in preclinical tumor angiogenesis research, but no clinical efficacy has been established.

• CD28–ARS2 Control of CD8+ T-Cell Metabolism

  2026-08-13

  The reference study identifies a CD28–ARS2 signaling axis that reshapes PKM alternative splicing, favoring PKM2 and enabling metabolic flexibility in activated CD8+ T cells. Its findings connect costimulatory signaling, RNA processing, glucose utilization, cytokine production, and antitumor function while suggesting complementary approaches for studying broader metabolic stress.

464 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page